Welcome to YLOAN.COM
yloan.com » Marketing » Cancer Market Outlook To 2015: Competitive Landscape, Market Size, Pipeline Analysis
Marketing Advertising Branding Careers-Employment Change-Management Customer Service Entrepreneurialism Ethics Marketing-Direct Negotiation Outsourcing PR Presentation Resumes-Cover-Letters Sales Sales-Management Sales-Teleselling Sales-Training Strategic-Planning Team-Building Top7-or-Top10-Tips Workplace-Communication aarkstore corporate advantages development collection global purchasing rapidshare grinding wildfire shipping trading economy wholesale agency florida attorney strategy county consumer bills niche elliptical

Cancer Market Outlook To 2015: Competitive Landscape, Market Size, Pipeline Analysis

Global cancer prevalence rates are on the rise owing to an aging population

, changing lifestyle and increasing pollution. Prevalence data is significantly influenced by the increasing diagnosis and survival rates across the global market.

The global cancer market is becoming increasingly competitive, with two therapeutic classes namely antineoplastics and cytostatic hormonal treatments dominating this sector. Collectively, the top 10 products in the global cancer market accounted for majority of the revenue in 2009.

Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because of a high number of unmet needs for improved treatments in different types of cancer. In 2009, around 40,000 Phase I, II and III trials were listed on ClinicalTrials.gov, and approximately 40% of these were related to cancer.

Targeted therapies are revolutionizing the paradigm of cancer treatment and are likely to be used in most cancer patients in the next 10 years. Due to the high incidence and subsequent potential for market success, breast cancer and NSCLC continue to drive high levels of R&D (along with niche indications such as NHL, RCC, CML, and prostate cancer).


Another factor that plays a major role for the growth in the cancer therapy market is expansion of the target indications. Most of the blockbuster drugs were launched for a narrow indication, and were later approved for other indications. A classic example is imatinib, which was first approved by the FDA in 2001 for the treatment of CML and later was expanded to around nine different indications.

Regardless of indication, the key challenge in ensuring the commercial success of pipeline drugs is to ascertain their integration into current treatment regimens either in combination with existing therapies or by demonstrating significant superiority over current treatments. Pricing risk remains the key investment concern in cancer. Moreover, the level of scrutiny by payors regarding the cost-effectiveness of cancer treatments has further intensified in the recent years.

Key Features of this report

Epidemiological analysis and forecast prevalence of the major cancer indications between 2009-15 including lung, breast, colorectal, and ovarian cancer markets.

Forecasts and analysis of the major products in the cancer market between 2009-15 spread across the major indications and classes of treatments.

Overview of key events in the global cancer market that have impacted treatment trends and sales potential across the major cancer indications.

Strategic and growth analysis of leading pharmaceutical corporations based on sales focus by drug class, currently marketed products and R&D product portfolios.

Detailed analysis across major classes of cancer treatments including antineoplastics and cytotoxic hormone therapies.

Detailed analysis of the clinically differentiated products in the cancer pipeline by indication and sales forecast of key R&D pipeline products in the global cancer market.

To know more about this report & to buy a copy please visit :

http://www.visionshopsters.com/product/3897/The-Cancer-Market-Outlook-to-2015-Competitive-landscape-market-size-pipeline-analysis-and-growth-opportunities.html

Contact us:

Visionshopsters


Ph : 91-22-40583020

Email: marketing@visionshopsters.com

Website : www.visionshopsters.com

by: Visionshopsters
The Biggest Money Saver In Today's Market - The Virtual Assistant Forex Ultimate System Review - Is Forex Ultimate System By Bob Iaccino A Scam? Stealth Traffic Formula Review - Is Stealth Traffic Formula A Scam? Make Money - How To Make Your Website Profitable With Google Adsense How Any Non Profit Org Can Help Its Members & Supporters With The Perfect Fundraising Program Top Strategies For Using Free Article Marketing To Build One Way Backlinks Get More Traffic With Marketing Articles How To Deal With The Valve Industry, Competition In The Market Last Year, Five Of This Year As Corporate Profits Shrink Or Reduce One Into A Textile Exports Article Marketing - The Perfect Viral Marketing Tool Domestic Exports Of Chinese Toys In 2010 Emerging Markets, Where To Go Global Weight Loss And Diet Management Market (2009 - 2014) Cheap Mobile Phone Plans Spending Made Profitable
print
www.yloan.com guest:  register | login | search IP(216.73.216.60) California / Anaheim Processed in 0.018873 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 40 , 3563, 66,
Cancer Market Outlook To 2015: Competitive Landscape, Market Size, Pipeline Analysis Anaheim